India vs Sub-Saharan Africa: Proportion of the target population who received a 3rd dose of
India
95.0%
in 2024
Sub-Saharan Africa
63.0%
in 2024
India rank
28th
Sub-Saharan Africa rank
25th
Proportion of the target population who received a 3rd dose of over time
- India
- Sub-Saharan Africa
How they compare
India currently reports 95.0% against 63.0% in Sub-Saharan Africa, a difference of 32.0%.
That makes India's figure about 1.5 times Sub-Saharan Africa's.
The two have swapped places 1 time across 7 shared years of data; in 2018 it was Sub-Saharan Africa ahead.
India ranks 28th and Sub-Saharan Africa ranks 25th of 157 countries.
Sub-Saharan Africa has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | India | Sub-Saharan Africa | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 10.5% | 70.5% | 60.0% | Sub-Saharan Africa |
| 2020s | 58.0% | 65.6% | 7.6% | Sub-Saharan Africa |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, India or Sub-Saharan Africa?
- India, at 95.0% against 63.0% in Sub-Saharan Africa as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between India and Sub-Saharan Africa?
- 32.0%, with India ahead.
- How many years of comparable data are there for India and Sub-Saharan Africa?
- 7 years are reported by both, from 2018 to 2024.
- How do India and Sub-Saharan Africa rank globally for proportion of the target population who received a 3rd dose of?
- India ranks 28th and Sub-Saharan Africa ranks 25th of 157 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.